InMed shares rise 12.08% intraday as shareholders approve directors and equity financing flexibility.

InMed surged 12.08% intraday following shareholder approval of directors and equity financing flexibility. Shareholders re-elected five directors and endorsed CBIZ CPAs P.C. as auditor, signaling corporate governance stability and potential capital-raising capabilities. The equity financing authorization likely boosted investor confidence in the company’s strategic flexibility, aligning with the sharp intraday price increase.